REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr.Max 96 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Lessors of Other Real Estate Property | Office Administrative Services
Full name: Dr.Max 96 S.R.O. Profile Updated: July 28, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 96 S.R.O. is an enterprise in Slovakia, with the main office in Kosice. The enterprise operates in the Pharmacies and Drug Stores industry. It was established on May 07, 2015. 5 - 9 (2025) employees currently work for Dr.Max 96 S.R.O.. The company’s latest financial report indicates a net sales revenue increase of 12.82% in 2024. There was a total growth of 15.63% in Dr.Max 96 S.R.O.’s total assets over the same period. In 2024, Dr.Max 96 S.R.O.’s net profit margin increased by 0.71%.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 96 S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 96 S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 96 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 96 S.R.O. report to view the information.
Incorporation Date:
May 07, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 96 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
12.82%
Total operating revenue
12.98%
Operating profit (EBIT)
54.77%
EBITDA
33.99%
Net Profit (Loss) for the Period
74.61%
Total assets
15.63%
Total equity
44.14%
Operating Profit Margin (ROS)
0.69%
Net Profit Margin
0.71%
Return on Equity (ROE)
5.34%
Debt to Equity Ratio
-1.08%
Quick Ratio
0.08%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?